PDK2
Basic information
Region (hg38): 17:50094737-50112152
Links
Phenotypes
GenCC
Source: 
ClinVar
This is a list of variants' phenotypes submitted to 
- not_specified (28 variants)
- not_provided (3 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the PDK2 gene is commonly pathogenic or not. These statistics are base on transcript: NM_000002611.5. Only rare variants are included in the table.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUSVUS | Likely benignLB | BenignB | Sum | 
|---|---|---|---|---|---|---|
| synonymous | 2 | |||||
| missense | 27 | 28 | ||||
| nonsense | 0 | |||||
| start loss | 0 | |||||
| frameshift | 0 | |||||
| splice donor/acceptor (+/-2bp) | 0 | |||||
| Total | 0 | 0 | 27 | 1 | 2 | 
GnomAD
Source: 
| Gene | Type | Bio Type | Transcript | Coding Exons | Length | 
|---|---|---|---|---|---|
| PDK2 | protein_coding | protein_coding | ENST00000503176 | 11 | 17416 | 
| pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p | 
|---|---|---|---|---|---|---|
| 0.00000371 | 0.950 | 125719 | 1 | 28 | 125748 | 0.000115 | 
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
|---|---|---|---|---|---|---|
| Missense | 2.05 | 155 | 245 | 0.632 | 0.0000142 | 2667 | 
| Missense in Polyphen | 59 | 95.652 | 0.61682 | 1043 | ||
| Synonymous | -0.958 | 116 | 104 | 1.12 | 0.00000691 | 773 | 
| Loss of Function | 1.85 | 12 | 21.2 | 0.567 | 0.00000115 | 230 | 
LoF frequencies by population
| Ethnicity | Sum of pLOFs | p | 
|---|---|---|
| African & African-American | 0.000183 | 0.000181 | 
| Ashkenazi Jewish | 0.00 | 0.00 | 
| East Asian | 0.000109 | 0.000109 | 
| Finnish | 0.0000469 | 0.0000462 | 
| European (Non-Finnish) | 0.000118 | 0.000114 | 
| Middle Eastern | 0.000109 | 0.000109 | 
| South Asian | 0.000200 | 0.000196 | 
| Other | 0.000657 | 0.000489 | 
dbNSFP
Source: 
- Function
- FUNCTION: Kinase that plays a key role in the regulation of glucose and fatty acid metabolism and homeostasis via phosphorylation of the pyruvate dehydrogenase subunits PDHA1 and PDHA2. This inhibits pyruvate dehydrogenase activity, and thereby regulates metabolite flux through the tricarboxylic acid cycle, down-regulates aerobic respiration and inhibits the formation of acetyl-coenzyme A from pyruvate. Inhibition of pyruvate dehydrogenase decreases glucose utilization and increases fat metabolism. Mediates cellular responses to insulin. Plays an important role in maintaining normal blood glucose levels and in metabolic adaptation to nutrient availability. Via its regulation of pyruvate dehydrogenase activity, plays an important role in maintaining normal blood pH and in preventing the accumulation of ketone bodies under starvation. Plays a role in the regulation of cell proliferation and in resistance to apoptosis under oxidative stress. Plays a role in p53/TP53-mediated apoptosis. {ECO:0000269|PubMed:17222789, ECO:0000269|PubMed:19833728, ECO:0000269|PubMed:21283817, ECO:0000269|PubMed:22123926, ECO:0000269|PubMed:7499431, ECO:0000269|PubMed:9787110}.;
- Pathway
- Signal Transduction;mtor signaling pathway;regulation of eif-4e and p70s6 kinase;pten dependent cell cycle arrest and apoptosis;skeletal muscle hypertrophy is regulated via akt-mtor pathway;Regulation of pyruvate dehydrogenase (PDH) complex;Pyruvate metabolism;Pyruvate metabolism and Citric Acid (TCA) cycle;The citric acid (TCA) cycle and respiratory electron transport;Metabolism;Signaling by Retinoic Acid;Signaling by Nuclear Receptors (Consensus) 
Recessive Scores
- pRec
- 0.172
Intolerance Scores
- loftool
- 0.575
- rvis_EVS
- -0.23
- rvis_percentile_EVS
- 37.11
Haploinsufficiency Scores
- pHI
- 0.0947
- hipred
- Y
- hipred_score
- 0.800
- ghis
- 0.536
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- S
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.978
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium | 
| Primary Immunodeficiency | Medium | Medium | Medium | 
| Cancer | Medium | Medium | Medium | 
Mouse Genome Informatics
- Gene name
- Pdk2
- Phenotype
- muscle phenotype;
Gene ontology
- Biological process
- glucose metabolic process;regulation of gluconeogenesis;protein phosphorylation;regulation of pH;insulin receptor signaling pathway;regulation of acetyl-CoA biosynthetic process from pyruvate;regulation of cellular ketone metabolic process;regulation of glucose metabolic process;cellular response to nutrient;cellular response to reactive oxygen species;glucose homeostasis;regulation of calcium-mediated signaling;intrinsic apoptotic signaling pathway by p53 class mediator
- Cellular component
- nucleoplasm;mitochondrion;mitochondrial matrix;cytosol;mitochondrial pyruvate dehydrogenase complex
- Molecular function
- protein kinase activity;pyruvate dehydrogenase (acetyl-transferring) kinase activity;ATP binding;protein homodimerization activity